Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy.

about

Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy.

Item

http://www.wikidata.org/entity/Q36391073

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Molecular Profiling of Refract ...... dictive Biomarkers to Therapy.

@ast

Molecular Profiling of Refract ...... dictive Biomarkers to Therapy.

@en

type

Item

label

Molecular Profiling of Refract ...... dictive Biomarkers to Therapy.

@ast

Molecular Profiling of Refract ...... dictive Biomarkers to Therapy.

@en

prefLabel

Molecular Profiling of Refract ...... dictive Biomarkers to Therapy.

@ast

Molecular Profiling of Refract ...... dictive Biomarkers to Therapy.

@en

P1476

Molecular Profiling of Refract ...... dictive Biomarkers to Therapy.

@en

P2093

Michael J Demeure

http://www.w3.org/2001/XMLSchema#string

Samuel Ejadi

http://www.w3.org/2001/XMLSchema#string

Sherri Z Millis

http://www.w3.org/2001/XMLSchema#string

P2860

Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel.

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomas

Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use.

Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer.

A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.

An eleven-year experience with adrenocortical carcinoma.

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.

P304

69-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/BIC.S34292

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26715866

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

4686344

http://www.w3.org/2001/XMLSchema#string